DAIC

OCTOBER 21, 2024

FDA approval for the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of paroxysmal atrial fibrillation and FDA 510(k) clearance for the new FARAVIEW Software, which will combine to provide visualization for cardiac ablation procedures with the FARAPULSE Pulsed Field Ablation System.

Ablation 59

Ablation Atrial Fibrillation Technology Electrophysiology 59

HeartRhythm

MAY 15, 2024

1 Catheter ablation for atrial fibrillation (AF) and ventricular tachycardia (VT) has become the standard of care for many patients presenting with these arrhythmias.2–4 1 Catheter ablation for atrial fibrillation (AF) and ventricular tachycardia (VT) has become the standard of care for many patients presenting with these arrhythmias.2–4

Electrophysiology 40

Electrophysiology Atrial Fibrillation Ablation Arrhythmia 40

DAIC

JULY 30, 2024

The Heart Rhythm Society (HRS) is preparing for HRX 2024, the third annual event of its kind, which will be held from September 5-7, 2024, in Atlanta, GA, gathering cardiovascular health innovators together to explore discoveries and advance partnerships between medicine and technology. On Thursday, Sept.

Heart Rhythm 105

Heart Rhythm Innovation Technology Education 105

DAIC

DECEMBER 26, 2023

a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial fibrillation, announced the completion of the first five procedures in its first-in-human feasibility study with its novel CellFX nsPFA cardiac catheter.

Ablation 59

Ablation Atrial Fibrillation Technology Hospital 59

Journal of Cardiovascular Electrophysiology

DECEMBER 7, 2023

Abstract Introduction Catheter ablation of atrial fibrillation (AF) has emerged as the most effective therapy. Conclusions It is a feasible and safe approach with support of transesophageal echocardiography and multiple emerging technologies.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Pacemaker Technology 40

DAIC

MARCH 26, 2024

The most common arrhythmia, atrial fibrillation , will affect approximately 12.1 Food and Drug Administration (FDA) in July 2023, a new leadless pacemaker system placed in both chambers of the heart and using a novel communication technology is now offering a more minimally invasive option for patients. Approved by the U.S.

Pacemaker 105

Pacemaker Heart Rhythm Arrhythmia Atrial Fibrillation 105

Journal of Cardiovascular Electrophysiology

DECEMBER 17, 2023

Among the four studied technologies, PFA was associated with the shortest procedure duration, the highest myocardial injury, and the lowest level of inflammation. Abstract Introduction Pulmonary vein isolation (PVI) using radiofrequency ablation (RFA) is an established treatment strategy for atrial fibrillation (AF).

Atrial Fibrillation 40

Atrial Fibrillation Ablation Technology Pulmonary 40

Journal of Cardiovascular Electrophysiology

JANUARY 10, 2024

Abstract Introduction Despite advanced ablation strategies and major technological improvements, treatment of persistent atrial fibrillation (AF) remains challenging and the underlying pathophysiology is not fully understood.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Outpatient Electrocardiogram 40

DAIC

FEBRUARY 29, 2024

24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023 Atrial Fibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

DAIC

DECEMBER 19, 2023

OSA is commonly seen in patients with arrhythmias like atrial fibrillation (AFib) and due to the variable unpredictable nature of sleep apnea symptoms, it is often untreated, leading to adverse outcomes. Western Regional Director of Cardiac Electrophysiology, Northwell Health , NY. David's Medical Center.

Heart Failure 52

Heart Failure Heart Disease Innovation Quality of Life 52

Journal of Cardiovascular Electrophysiology

NOVEMBER 6, 2024

This study aims to identify factors leading to insufficient lesions during pulmonary vein antral isolation (PVAI) with vHPSD-ablation and to develop an optimized PVAI strategy using this technology. Methods PVAI was performed on 41 atrial fibrillation patients using vHPSD-ablation (90W/4s).

Ablation 40

Ablation Atrial Fibrillation Technology Pulmonary 40

Journal of Cardiovascular Electrophysiology

MARCH 4, 2024

Matched control cases were enrolled in reverse chronological order beginning on the last day for which the technology was unavailable. Results The study group consisted of 28 patients (age 65 ± 11 years, 46% female, left atrial dimension 4.1 ± 0.9 cm, cm, LVEF 50 ± 18%) and was similar to 28 controls. vs. 33.2 ± 18.0

Arrhythmia 40

Arrhythmia Ablation Tachycardia Atrial Fibrillation 40

Journal of Cardiovascular Electrophysiology

DECEMBER 7, 2023

Abstract Background The newly introduced nonthermal pulsed field ablation (PFA) is a promising technology to achieve fast pulmonary vein isolation (PVI) with high acute success rates and good safety features. PFA versus VHPSD for PVI. Data comparing PFA to VHPSD-PVI is lacking. For PFA-PVI a pentaspline 20 electrode catheter was used.

Ablation 40

Ablation Pulmonary Arrhythmia Atrial Fibrillation 40

DAIC

FEBRUARY 14, 2025

In particular, the study showed superiority in the percentage of patients that achieved freedom from atrial fibrillation (AF) with or without anti-arrhythmic drugs at 12 months after a tailored cardiac ablation guided by AI in combination with PVI when compared to PVI alone. tim.hodson Fri, 02/14/2025 - 09:57 Feb. adult population.

Atrial Fibrillation 52

Atrial Fibrillation Ablation Technology Pulmonary 52

DAIC

MAY 18, 2024

During its Annual Conference, HRS 2024, the Heart Rhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrial fibrillation (AF). See full findings from the FARADISE, admIRE Study, and Advent Trial here.

Heart Rhythm 105

Heart Rhythm Atrial Fibrillation Ablation Quality of Life 105

DAIC

JULY 24, 2024

Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population.

Atrial Fibrillation 105

Atrial Fibrillation AFIB Ablation Technology 105

DAIC

DECEMBER 14, 2023

This is the first PFA technology to receive FDA approval and follows the recent European CE (Conformité Européenne) Mark of the PulseSelect PFA system in November. This is the first PFA technology to receive FDA approval and follows the recent European CE (Conformité Européenne) Mark of the PulseSelect PFA system in November.

Atrial Fibrillation 105

Atrial Fibrillation Ablation Technology Heart Failure 105

DAIC

FEBRUARY 2, 2024

milla1cf Fri, 02/02/2024 - 17:18 February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 with CardioLab EP Recording system, to help clinicians in the diagnosis and treatment of cardiac arrhythmias. Usman Siddiqui , Director of Electrophysiology. [5]

Electrophysiology 101

Electrophysiology Innovation AFIB Atrial Fibrillation 101

DAIC

APRIL 9, 2024

An international consensus statement on how to treat atrial fibrillation with catheter or surgical ablation has been published in EP Europace, a journal of the European Society of Cardiology (ESC), and was recently presented at EHRA 2024, a scientific congress held April 7-9 in Berlin, Germany.

Atrial Fibrillation 105

Atrial Fibrillation Ablation Heart Rhythm Blood Clot 105

DAIC

FEBRUARY 12, 2024

milla1cf Mon, 02/12/2024 - 15:18 February 12, 2024 — BIOTRONIK , a leader in implantable medical device technology, announced today they will solely supply their proprietary DX models for new single-chamber ICD implants moving forward. Journal of Cardiovascular Electrophysiology, Volume 30, Issue 10, October 2019, Pages 1994–2001.

Technology 64

Technology Atrial Fibrillation Defibrillator Sudden Cardiac Death 64

DAIC

MARCH 27, 2025

tim.hodson Thu, 03/27/2025 - 12:18 March 27, 2025 Abbott recently announced it has received CE Mark in Europe for the Volt PFA System to treat patients battling atrial fibrillation (AFib). The One System Solution provided by EnSite X can accommodate all EP procedures and compatible technologies. 1 Fact Sheets for Press.

Ablation 52

Ablation AFIB Atrial Fibrillation Electrophysiology 52

DAIC

APRIL 5, 2024

The transaction follows Johnson & Johnson MedTech’s successful acquisitions of Abiomed , a leader in heart recovery, and more recently Laminar, an innovator in left atrial appendage elimination for patients with non-valvular atrial fibrillation (AFib).

Cardiovascular Interventions 105

Cardiovascular Interventions Technology Innovation Angina 105

DAIC

MARCH 5, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech , today announced European CE mark approval of the VARIPULSE Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation ( AF ) using pulsed field ablation (PFA). Atrial Fibrillation. Circulation.

Ablation 59

Ablation Atrial Fibrillation Atrial Flutter Pulmonary 59

DAIC

JUNE 19, 2024

By the 1960s, advances in technology and medical research led to the emergence of automated ECG interpretation (AEI), based on physician-developed rules of classification. By 1909 ECGs were being used to diagnose cases of arrhythmia; by 1910 to diagnose indicators of a heart attack.

AFIB 105

AFIB Reimbursement Research Atrial Fibrillation 105

Journal of Cardiovascular Electrophysiology

MARCH 19, 2025

ABSTRACT Introduction Pulmonary vein isolation (PVI) using a cryoballoon is well-established for the treatment of paroxysmal atrial fibrillation (PAF). Compared to other available technologies, the usage of a stable, low-pressure cryoballoon (POLARx, Boston Scientific) has demonstrated lower nadir temperatures and longer thawing times.

Atrial Fibrillation 40

Atrial Fibrillation Myocardial Infarction Pulmonary Technology 40

Journal of Cardiovascular Electrophysiology

DECEMBER 7, 2023

Abstract Introduction Pulsed field ablation (PFA) is a new ablation technology for atrial fibrillation (AF). Data regarding early recurrences of atrial tachyarrhythmia (ERAT) after PFA-pulmonary vein isolation (PVI) are sparse. Methods Consecutive patients with symptomatic AF were enrolled to undergo PFA-PVI.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Document Tachycardia 40

DAIC

JULY 8, 2024

Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology at Icahn Mount Sinai. Dr. Reddy serves as an unpaid consultant to Boston Scientific, the manufacturer of the PFA catheter technology studied in this manuscript. and Harry B.

Atrial Fibrillation 105

Atrial Fibrillation Ablation Pulmonary Heart Rhythm 105

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The Society (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

CardiacWire

NOVEMBER 6, 2024

Boston Scientific made what could become a major addition to its electrophysiology portfolio, acquiring AFib mapping startup Cortex, Inc. Cortex gives Boston Scientific a new mapping technology that detects AFib signs and triggers outside of the pulmonary veins, and can help EP teams develop ablation strategies for more complex AFib cases.

AFIB 105

AFIB Electrophysiology Ablation Technology 105

Journal of Cardiovascular Electrophysiology

APRIL 7, 2025

ABSTRACT Background Factors contributing to early recurrence after atrial fibrillation (AF) ablation, particularly with pulsed-field ablation (PFA), are poorly understood. Trial Registration: Advanced TecHnologies For SuccEssful AblatioN of AF in Clinical Practice (ATHENA). URL: [link]. Identifier: NCT05617456.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Technology Arrhythmia 40

DAIC

OCTOBER 30, 2024

With this approval, Medtronic now offers two PFA technologies available for patients with Afib. The Affera system was designed to address procedural challenges faced by the electrophysiology community while maintaining a high standard of safety and efficacy for patients. tim.hodson Wed, 10/30/2024 - 13:42 Oct.

Ablation 52

Ablation AFIB Atrial Fibrillation Atrial Flutter 52